DK0682947T3 - Medikament til terapeutisk og profylaktisk behandling af sygdomme forårsaget af glatmuskelcelle-hyperplasi - Google Patents

Medikament til terapeutisk og profylaktisk behandling af sygdomme forårsaget af glatmuskelcelle-hyperplasi

Info

Publication number
DK0682947T3
DK0682947T3 DK95107372.5T DK95107372T DK0682947T3 DK 0682947 T3 DK0682947 T3 DK 0682947T3 DK 95107372 T DK95107372 T DK 95107372T DK 0682947 T3 DK0682947 T3 DK 0682947T3
Authority
DK
Denmark
Prior art keywords
therapeutic
smooth muscle
muscle cell
prophylactic treatment
medication
Prior art date
Application number
DK95107372.5T
Other languages
English (en)
Inventor
Kumi Yamada
Yoshikuni Tamao
Masahiro Ohshima
Norimichi Iwase
Original Assignee
Mitsubishi Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Corp filed Critical Mitsubishi Chem Corp
Application granted granted Critical
Publication of DK0682947T3 publication Critical patent/DK0682947T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
DK95107372.5T 1994-05-19 1995-05-16 Medikament til terapeutisk og profylaktisk behandling af sygdomme forårsaget af glatmuskelcelle-hyperplasi DK0682947T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10536794 1994-05-19

Publications (1)

Publication Number Publication Date
DK0682947T3 true DK0682947T3 (da) 1998-05-04

Family

ID=14405751

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95107372.5T DK0682947T3 (da) 1994-05-19 1995-05-16 Medikament til terapeutisk og profylaktisk behandling af sygdomme forårsaget af glatmuskelcelle-hyperplasi

Country Status (9)

Country Link
US (1) US5643911A (da)
EP (1) EP0682947B1 (da)
CN (1) CN1116526A (da)
AT (1) ATE157871T1 (da)
CA (1) CA2149691A1 (da)
DE (1) DE69500673T2 (da)
DK (1) DK0682947T3 (da)
ES (1) ES2109752T3 (da)
GR (1) GR3025568T3 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716956A (en) * 1995-06-07 1998-02-10 Bearsden Bearsden Bio, Inc. Dihydrophthalazine antagonists of excitatory amino acid receptors
CN1103591C (zh) * 1996-05-22 2003-03-26 永光制药有限公司 取代的1,4,5,6－四氢哒嗪并[4,5－c]哒嗪－5－酮类化合物之药物组合物及其应用和制备方法
US6689883B1 (en) 1999-09-28 2004-02-10 Bayer Pharmaceuticals Corporation Substituted pyridines and pyridazines with angiogenesis inhibiting activity
US7977333B2 (en) 2000-04-20 2011-07-12 Bayer Healthcare Llc Substituted pyridines and pyridazines with angiogenesis inhibiting activity
US6903101B1 (en) 2000-08-10 2005-06-07 Bayer Pharmaceuticals Corporation Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
SI1454903T1 (sl) * 2001-12-11 2010-12-31 Kyowa Hakko Kirin Co Ltd Tiadiazolinski derivati za zdravljenje raka
EP2174605B1 (en) * 2002-11-08 2012-07-11 Tyco Healthcare Group LP Self-sealing cannula
JPWO2004089412A1 (ja) * 2003-04-08 2006-07-06 三菱ウェルファーマ株式会社 特異的ｎａｄ（ｐ）ｈオキシダーゼ抑制剤
JP4676881B2 (ja) * 2003-04-18 2011-04-27 協和発酵キリン株式会社 Ｍ期キネシン阻害剤
US20070276017A1 (en) * 2003-06-10 2007-11-29 Chikara Murakata Thiadiazoline Derivative
US20080262049A1 (en) * 2005-03-22 2008-10-23 Kyowa Hakko Kogyo Co., Ltd. Therapeutic Agent for Hematopoietic Tumor
AU2006225636A1 (en) * 2005-03-22 2006-09-28 Fujifilm Corporation Therapeutic agent for solid tumor
WO2006137490A1 (ja) * 2005-06-24 2006-12-28 Kyowa Hakko Kogyo Co., Ltd. 再狭窄治療剤
US8025640B2 (en) 2008-06-27 2011-09-27 Tyco Healthcare Group Lp Pressurized surgical valve

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3738371A (en) 1970-12-11 1973-06-12 Esb Inc Cardiac pacers with source condition-responsive rate
JPS5653659A (en) 1979-10-09 1981-05-13 Mitsubishi Yuka Yakuhin Kk Blood platelet coagulation suppressing agent
JPS5653660A (en) 1979-10-09 1981-05-13 Mitsubishi Yuka Yakuhin Kk 4-phenylphthalazine derivative
JPS5748972A (en) 1980-09-10 1982-03-20 Mitsubishi Yuka Yakuhin Kk 4-phenylphthalazine derivative
JPS5738715A (en) 1980-08-18 1982-03-03 Mochida Pharmaceut Co Ltd Medical composition having activity of prohibiting artery wall from thickening
JPS60218377A (ja) 1984-04-16 1985-11-01 Mitsubishi Yuka Yakuhin Kk ４−フエニルフタラジン誘導体及びそれを有効成分とする循環改善剤
JPS60243074A (ja) 1985-04-15 1985-12-03 Mitsubishi Yuka Yakuhin Kk ４−フエニルフタラジン誘導体
ZA896851B (en) 1988-09-14 1990-06-27 Hoffmann La Roche Use of ace-inhibitors
DE3926606A1 (de) 1989-08-11 1991-02-14 Hoechst Ag Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie
JPH0383923A (ja) 1989-08-25 1991-04-09 Terumo Corp 中膜平滑筋細胞の遊走阻害剤
JPH03106873A (ja) * 1989-09-20 1991-05-07 Morishita Pharmaceut Co Ltd １―ピリジルフタラジン誘導体及びそれらを含有する血小板凝集抑制剤
JP2852538B2 (ja) 1989-09-29 1999-02-03 第一製薬株式会社 〔１，２，４〕トリアゾロ〔１，５―ａ〕ピリミジン誘導体
EP0449203B1 (en) * 1990-03-30 1994-12-07 Mitsubishi Chemical Corporation 4-Phenylphthalazine derivatives
JPH04211666A (ja) 1990-03-30 1992-08-03 Mitsubishi Kasei Corp ４−フェニルフタラジン誘導体
JP2999808B2 (ja) 1990-08-20 2000-01-17 第一製薬株式会社 ２位置換トリアゾロピリミジン類
JPH04154720A (ja) 1990-10-16 1992-05-27 Terumo Corp カテコール誘導体及びこれを含有する血管壁肥厚防止薬
TW279162B (da) 1991-09-26 1996-06-21 Mitsubishi Chem Corp

Also Published As

Publication number Publication date
DE69500673T2 (de) 1998-03-19
EP0682947A1 (en) 1995-11-22
CA2149691A1 (en) 1995-11-20
ATE157871T1 (de) 1997-09-15
US5643911A (en) 1997-07-01
ES2109752T3 (es) 1998-01-16
CN1116526A (zh) 1996-02-14
GR3025568T3 (en) 1998-03-31
DE69500673D1 (de) 1997-10-16
EP0682947B1 (en) 1997-09-10

Similar Documents

Publication Publication Date Title
ATE181080T1 (de) Hiv-proteaseinhibitoren
NO20060971L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
NO950297D0 (no) Prolinamidderivater
NO20020968D0 (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
DK0682947T3 (da) Medikament til terapeutisk og profylaktisk behandling af sygdomme forårsaget af glatmuskelcelle-hyperplasi
NO975666D0 (no) Pyrroldovater og medisinsk sammensetning
DK0950057T3 (da) 3-pyridylenantiomerer og deres anvendelse som analgetika
DE60025848D1 (en) Pyrimidin-derivate als selective inhibitoren von cox-2
DK0998287T3 (da) Anvendelse af levobupivacain
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
DK0652000T3 (da) Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et lægemiddel til inhibering af angiogenese og angiogene sygdomme
DK1228758T3 (da) Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom
DK0559145T3 (da) Lægemiddel til truende abort
FI964303A (fi) Keuhkosydänvian hoitamiseen tarkoitettu aine
SE0004827D0 (sv) Therapeutic compounds
NO993911D0 (no) Remedier/Forebygningsmidler for åndedrettssykdommer
DK0784973T3 (da) Quinoxalinderivater til behandling af tinnitus
WO1998038985A3 (en) Use of carvedilol for the manufacture of a medicament for preventive and therapeutic treatment of inflammatory diseases
DE60026559D1 (de) Arzneimittel gegen essstörungen
DE69722630D1 (de) Therapeutisches mittel zur behandlung von nierenerkrankungen
DK653687D0 (da) Middel til behandling af nyresygdomme
TH63164A (th) โพรดรักของอนุพันธ์ 3-(ไพรโรล-2-อิลเมธิลิดีน)-2-อิลโดลิโนน